| | Hang Seng Index | 26.040 HKD | +0.320 | +1.244% | 442.97M | 11.44B | 26.006 (+0.131%) HKD as at 2026/03/12 | | |
| | Hang Seng TECH Index | 4.978 HKD | +0.108 | +2.218% | 1.41B | 6.89B | 4.914 (+1.294%) HKD as at 2026/03/12 | | |
| | Hang Seng China Enterprises Index | 89.880 HKD | +1.180 | +1.330% | 65.16M | 5.81B | 89.071 (+0.908%) HKD as at 2026/03/12 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | SK hynix Inc. | 28.640 HKD | +2.240 | +8.485% | 43.56M | 1.23B | 26.751 (+7.063%) HKD as at 2026/03/13 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 4.204 HKD | +0.190 | +4.733% | 193.34M | 789.81M | 4.039 (+4.077%) HKD as at 2026/03/13 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Samsung Electronics Co Ltd | 70.120 HKD | +1.960 | +2.876% | 7.49M | 519.49M | 68.425 (+2.477%) HKD as at 2026/03/13 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.632 HKD | -0.078 | -4.561% | 201.13M | 337.86M | 1.705 (-4.304%) HKD as at 2026/03/13 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.776 HKD | -0.042 | -2.310% | 100.10M | 180.53M | 1.831 (-2.977%) HKD as at 2026/03/13 | | |
| | Hang Seng TECH Index (net total return version) | 10.660 HKD | +0.230 | +2.205% | 16.10M | 169.20M | 10.538 (+1.156%) HKD as at 2026/03/12 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.830 HKD | +0.140 | +2.460% | 28.10M | 161.06M | 5.660 (+3.000%) HKD as at 2026/03/13 | | |
| | Hang Seng High Dividend 30 Index (price return version) | 21.480 HKD | -0.200 | -0.923% | 5.86M | 125.60M | 21.876 (-1.811%) HKD as at 2026/03/12 | | |
| | London Gold Fixing Price | 3,609.000 HKD | -47.000 | -1.286% | 31.78K | 114.42M | 476.190 (-3.184%) USD as at 2026/03/11 | | |
| | | 9.825 HKD | +0.095 | +0.976% | 11.29M | 110.25M | 9.749 (+0.780%) HKD as at 2026/03/12 | | |
| | Hang Seng TECH Index | 5.060 HKD | +0.102 | +2.057% | 21.64M | 107.88M | 5.000 (+1.206%) HKD as at 2026/03/12 | | |
| | Hang Seng TECH Index | 6.445 HKD | +0.135 | +2.139% | 16.56M | 105.42M | 6.316 (+2.046%) HKD as at 2026/03/13 | | |
| | CSI 300 Index | 54.560 HKD | -0.240 | -0.438% | 1.46M | 79.62M | 55.292 (-1.324%) HKD as at 2026/03/12 | | |
| | | 8.360 HKD | +0.085 | +1.027% | 5.90M | 49.05M | 8.287 (+0.883%) HKD as at 2026/03/12 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 33.840 HKD | -0.920 | -2.647% | 1.08M | 36.24M | 35.231 (-3.949%) HKD as at 2026/03/12 | | |
| | S&P GSCI Crude Oil Multiple Contract 55/30/15 1M/2M/3M (USD) ER Index | 10.140 HKD | +0.120 | +1.198% | 3.45M | 34.77M | 9.854 (+2.902%) HKD as at 2026/03/12 | | |
| | Hang Seng Biotech Index | 14.370 HKD | +0.310 | +2.205% | 2.16M | 30.70M | 14.093 (+1.968%) HKD as at 2026/03/13 | | |
| | FTSE ETF Connect East-West Succession Equity Select Index (net total return version) | 11.070 HKD | -0.010 | -0.090% | 2.42M | 26.62M | 11.264 (-1.723%) HKD as at 2026/03/12 | | |
| | LBMA Gold Price AM | 15.850 HKD | -0.200 | -1.246% | 1.57M | 24.70M | 16.333 (-2.955%) HKD as at 2026/03/12 | | |
| | FTSE China A50 Index | 16.210 HKD | +0.070 | +0.434% | 1.43M | 23.06M | 16.225 (-0.091%) HKD as at 2026/03/12 | | |
| | | 8.385 HKD | +0.135 | +1.636% | 2.62M | 21.69M | 8.280 (+1.263%) HKD as at 2026/03/12 | | |
| | S&P GSCI Crude Oil Enhanced Index Excess Return | 7.945 HKD | +0.120 | +1.534% | 2.69M | 21.18M | 7.675 (+3.518%) HKD as at 2026/03/12 | | |
| | Hang Seng High Dividend Yield Index | 33.220 HKD | -0.220 | -0.658% | 552.80K | 18.37M | 33.753 (-1.579%) HKD as at 2026/03/12 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.472 HKD | -0.024 | -0.686% | 4.20M | 14.65M | 3.465 (+0.190%) HKD as at 2026/03/12 | | |
| | CSI 300 Index | 48.100 CNY | -0.700 | -1.434% | 270.60K | 12.99M | 48.636 (-1.102%) CNY as at 2026/03/12 | | |
| | London Gold Fixing Price | 23.640 HKD | -0.320 | -1.336% | 434.59K | 10.25M | 23.968 (-1.370%) HKD as at 2026/03/13 | | |
| | Bloomberg APAC High Dividend 40 Net Return Index HKD | 14.850 HKD | -0.100 | -0.669% | 583.00K | 8.66M | 15.003 (-1.022%) HKD as at 2026/03/12 | | |